DA Davidson raises Progress Software stock price target to $75 on acquisition

DA Davidson reiterated a Buy rating on Progress Software (PRGS), raising its price target to $75, following the company's strong second-quarter performance which saw EPS beat expectations and Annual Recurring Revenue (ARR) surge 46% year-over-year to $838 million, despite a slight revenue miss. The firm highlighted Progress's consistent business strength, impressive 85.71% gross margins, and strategic acquisition of AI-focused Nuclia for $20 million, which enhances its product portfolio. Progress also raised its full-year 2025 guidance, underscoring confidence in its disciplined M&A strategy and ability to deliver strong inorganic growth.

Analysis

DA Davidson has reiterated its Buy rating for Progress Software (PRGS) and increased its price target to $75.00, citing a strategy centered on strong inorganic growth and best-in-class margins. This confidence is underpinned by the company's second-quarter fiscal 2025 results, where it delivered an EPS of $1.40, surpassing the $1.30 analyst consensus, despite a marginal revenue miss of $237 million against a $237.53 million forecast. The company's financial strength is evident in its robust 46% year-over-year growth in Annual Recurring Revenue (ARR) to $838 million, an impressive 85.71% gross profit margin, and a 40% operating margin. The firm's M&A strategy appears to be executing effectively, with the integration of its previous acquisition, ShareFile, reportedly tracking ahead of schedule. Progress Software is continuing this strategy with the $20 million acquisition of Nuclia, an AI-focused service provider, to enhance its platform's capabilities. Reflecting this positive momentum and strategic direction, management has raised its full-year 2025 guidance for both revenue (to $962-$974 million) and EPS (to $5.28-$5.40).

Key Decisions for Investors

• Investors should consider Progress Software's proven growth-by-acquisition model, validated by strong ARR growth of 46% and high profitability, as the core thesis for a long position, especially with the raised full-year guidance and analyst price target suggesting significant upside.
• The slight Q2 revenue miss, juxtaposed with the reliance on M&A, highlights that a key risk to monitor is the execution and integration of new acquisitions like Nuclia to ensure they translate into sustained top-line growth.
• Given the stock's current price of $58.22 is well below DA Davidson's new $75.00 target, investors might view the present level as a favorable entry point, contingent on their confidence in management's ability to continue its disciplined and successful M&A strategy.